Anil Kumar
About Anil Kumar
Data last updated:
Anil Kumar is a Director at Cathartic Pharmaceuticals Private Limited (since 2018) and Director at Yanksan Healthcare Private Limited (since 2022). The companies operate in Pharma. The largest current company by reported revenue is Cathartic Pharmaceuticals Private Limited at ₹31.3 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cathartic Pharmaceuticals Private Limited U74999HR2018PTC072979 | Director | 12 Mar 2018 | 2018 | ₹31.3 Lakh (FY 2024) | Active |
| Yanksan Healthcare Private Limited U24290HR2022PTC102751 | Director | 11 Apr 2022 | 2022 | Active |
Board colleagues of Anil Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Geeta | 08083767 | Cathartic Pharmaceuticals Private Limited , Yanksan Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anil Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anil Kumar
Anil Kumar currently holds 2 directorships: Cathartic Pharmaceuticals Private Limited (Director, since 12 Mar 2018, revenue ₹31.3 Lakh (FY 2024)); Yanksan Healthcare Private Limited (Director, since 11 Apr 2022).
Anil Kumar was first appointed on 12 Mar 2018 as Director at Cathartic Pharmaceuticals Private Limited. The most recent appointment on record is 11 Apr 2022 at Yanksan Healthcare Private Limited.
The current boards of Anil Kumar's companies include Geeta (Cathartic Pharmaceuticals Private Limited).